Nigeria Seeks Ugandan Partnership to Ease Sickle-Cell Burden 🇺🇬🇳🇬 🇺🇬🇳🇬 Partnerships with Ugandan pharmaceutical companies to improve treatment access are being explored, a senior official said at the Nigeria-Uganda Business Forum and Exhibition 2026 in Kampala. Key details: 🟠Scale of Crisis: Nigeria has the world's highest number of sickle-cell sufferers, with an estimated 150,000 newborns affected annually, per WHO. 🟠Ugandan Solution: Quality Chemical Industries Limited in March launched hydroxyurea, a new sickle-cell medication, with the capacity to produce 1.4 billion tablets annually. 🟠Partnership: Nigeria will work with the Ugandan company to make the drugs available to patients, Dr. Ibrahim Abubakar Kana, Permanent Secretary in the Office of the Secretary to the Government of Nigeria, said. 🟠Population Dynamics: Nigeria's large population—over 200 million—amplifies disease burdens, resulting in higher absolute numbers even if prevalence rates are similar, Dr. Kana noted. Subscribe to @sputnik_africa 🔸 Sputnik Africa | X 🔸